Providing an Overview of How Sutro Biopharma Are Targeting Folate Receptor α

Time: 4:00 pm
day: day 2- pm

Details:

  • Discussing STRO-002 Phase 1 Clinical Study for patients with Advanced Ovarian Cancer as well as other indications
  • Outlining how Sutro Biopharma are targeting FOLR-alpha

Speakers: